Patient participation and compliance in cancer chemoprevention trials: Issues and concerns

Proceedings of the Society for Experimental Biology and Medicine

Volumn 216, Issue 2, 1997, Pages 260-265

  Tangrea, Joseph A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PREVENTION; CANCER RESEARCH; CLINICAL PROTOCOL; HUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN;

EID: 0030823141     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44176     Document Type: Article

References (38)

1. Byar DP, Simon RM, Freidewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, Gail MH, Wave JH. Randomized clinical trials: Perspectives on some recent ideas. N Engl J Med 295:74-80, 1976.
2. Byar DP, Freedman LS. The importance and nature of cancer prevention trials. Semin Oncol 17:413-424, 1990.
3. Nixon DW. Special aspects of cancer prevention trials. Cancer 74:2683-2686, 1994.
4. Malone WF, Kelloff GJ, Boone C, Nixon DW. Chemoprevention and modern cancer prevention. Prev Med 18:553-561, 1989.
5. Greenwald P. Epidemiology: A step forward in the scientific approach to preventing cancer through chemoprevemion. Public Health Rep 99:259-264, 1984.
6. Turk DC. Nonadherence to chemoprevention regimens: A ton of prevention. Prog Clin Biol Res 339:139-149, 1990.
7. Agras WS, Bradford RH. Recruitment: An introduction. Circulation 66:2-5, 1982.
8. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: Literature summary and annotated bibliography. Control Clin Trials 8:6S-30S, 1987.
9. Hjorth M, Holmberg E, Rodjer S, Taube A, Westin J. Physicians' attitudes toward clinical trials and their relationship to patient accrual in a Nordic multicenter study on myeloma. Control Clin Trials 17:372-386, 1996.
10. Mansour EG. Barriers to clinical trials: Part III: Knowledge and attitudes of health care providers. Cancer 74:2672-2675, 1994.
11. Benson AB, Prokop Pregler J, Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: An Illinois Cancer Center study. J Clin Oncol 9:2067-2075, 1991.
12. Joseph RR. Viewpoints and concerns of a clinical trial participant. Cancer 74:2692-2693, 1994.
13. Rimer BK, Engstrom PF. Participation in macronutrient trials. In: Macronutrients: Investigating Their Role in Cancer. Micozzi MS, Moon TE, Ed. New York: Marcel Dekker, 1992.
14. Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes towards clinical trials among patients and the public. JAMA 248:968-970, 1982.
15. Hassar M, Weintraub M. "Uninformed" consent and the wealthy volunteer: An analysis of patient volunteers in a clinical trial of a new anti-inflammatory drug. Clin Pharmacol Ther 20:379-386, 1976.
16. Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Informed consent: Why are its goals imperfectly realized? N Engl J Med 302:896-900, 1980.
17. Novak E, Seckman CE, Steward RD. Motivations for volunteering as research subjects. J Clin Pharmacol 17:365-371, 1977.
18. McCusker J, Wax A, Bennett JM. Cancer patients accessions into clinical trials: A pilot investigation into some patient and physician determinants of entry. Am J Clin Oncol 5:227-236, 1982.
19. Tangrea JA, Adrianza ME, Helsel WE. Patients' perceptions on participation in a cancer chemoprevention trial. Cancer Epidemiol Biomarkers Prev 1:325-330, 1992.
20. Bevan EG, Chee LC, McGhee M, McInnes GT. Patients' attitudes to participation in clinical trials. Br J Clin Pharmacol 35:204-207, 1993.
21. Winn RJ. Obstacles to the accrual of patients in clinical trials in the community setting. Semin Oncol 21:112-117, 1994.
22. Schain WS. Barriers to clinical trials. Part II: Knowledge and attitudes of potential participants. Cancer 74:2666-2671, 1994.
23. Taylor KM, Kelner M. Interpreting physician participation in randomized clinical trials: The physician orientation profile. J Health Soc Behav 28:389-400, 1987.
24. Fisher B. On clinical trial participation. J Clin Oncol 9:1927-1930, 1991.
25. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 32:35-42, 1991.
26. Mattson ME, Curb JD, McArdle R, and the AMIS and BHAT Research Groups. Participation in a clinical trial: The patients' point of view. Control Clin Trials 6:156-167, 1985.
27. Mettlin C, Cummings KM, Walsh D. Risk factor and behavioral correlates of willingness to participate in cancer prevention trials. Nutr Cancer 7:189-198, 1985.
28. Baron JA. Compliance issues/biological markers. In: Sestili MA, Ed. Chemoprevention Clinical Trials: Problems and Solutions. Bethesda, MD: National Institutes of Health, NIH Publication No. 85-2715, 1984.
29. Rimer BK, Glanz K, Lerman C. Contributions of public health to patient compliance. J Community Health 16:225-240, 1991.
30. Stevens MM, Greenberg ER, Baron JA. Practical aspects of cancer prevention trials. In: Moon TE, Micozzi MS, Eds. Nutrition and Cancer Prevention: Investigating the Role of Micronutrients. New York: Marcel Dekker, 1989.
31. Rimer BK. Participant enrollment, participation and compliance in chemoprevention trials. In: The Biology and Prevention of Aerodigestive Tract Cancers. Newell GR, Hong WK, Eds. New York: Plenum Press, 1992.
32. Becker MH, Maiman LA. Strategies for enhancing patient compliance. J Community Health 6:113-135, 1980.
33. Tangrea JA, Edwards BK, Hartman A, Taylor P, Peck G, Salasche S, Menon P, Winton G, Mellette R, Guin J, Stoll H, and the ISO-BCC Study Group. Isotretinoin-Basal Cell Carcinoma Prevention Trial: design, recruitment results, and baseline characteristics of the trial participants. Control Clin Trials 11:433-450, 1990.
34. Roberson NL. Clinical trial participation: Viewpoints from racial/ ethnic groups. Cancer 74:2687-2691, 1994.
35. Wermeling DP, Selwitz AS. Current Issues surrounding women and minorities in clinical trials. Ann Pharmacother 27:904-911, 1993.
36. Freeman HP. The impact of clinical trial protocols on patient care systems in a large city hospital: Access for the socially disadvantaged. Cancer 72:2834-2838, 1993.
37. Harris Y, Gorelick PB, Samuels P, Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc 88:630-634, 1996.
38. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: Toward a participant-friendly system. J Natl Cancer Inst 87:1749-1759, 1995.